News

Congratulations to Pamela Ronald for being named GCHERA World Agriculture Prize Laureate

October 21, 2020

Pamela Ronald, distinguished professor in the Department of Plant Pathology at the University of California, Davis, and with the UC Davis Genome Center, has been named a 2020 World Agriculture Prize laureate by the Global Confederation of Higher Education Associations for Agricultural and Life Sciences, or GCHERA. She becomes the first woman whose work is recognized by the award.

Congratulations to Ilias Tagkopoulos for Being Awarded a Grant to Establish a New Food Systems Institute

September 02, 2020

The University of California, Davis, has been awarded $20 million as part of a multi-institutional collaboration to establish an institute focused on enabling the next-generation food system through the integration of artificial intelligence, or AI, technologies. The award is part of a larger investment announced today (Aug. 26) by the National Science Foundation, or NSF, in partnership with several federal agencies — distributing a total of $140 million to fund seven complementary AI research institutes across the nation.

Congratulations to the Earth Biogenome Project

March 03, 2020

We congratulate the Earth Biogenome Project for their recent funding acquired from Pacific Biosciences to support the sequencing of ecologically important organisms in California. You can read the full press release on the PacBio website.

David L. Weaver Endowed Lecture 2020-Canceled

February 20, 2020
The Genome Center is pleased to announce that Jack Szostak will be the featured lecturer at the 2020 David L. Weaver Endowed Lecture. The 2020 David L. Weaver Lecture has been canceled for April 2020. 

UC Davis launches center to advance genome-editing tools

June 03, 2019
A new center will serve as the nation's testing site for safety and efficacy (SACRAMENTO). UC Davis today announced the launch of a new National Institutes of Health (NIH) funded research center dedicated to helping the nation develop safe and effective genome editing tools to treat patients with both common and rare diseases.